Senior Director, Clinical Pharmacology & PK/PD Strategy

BioSpace; South San Francisco (CA); Sur place; USD 180 000 - 240 000; Plein temps

Avantages offerts par ce poste

Medical insurance

401(k)

Paid time off

Résumé du poste

AbbVie in the United States seeks an experienced Clinical Pharmacology leader to conceive, execute and manage multi-disciplinary PK/PD development plans that meet commercial and regulatory aims. You will lead PK/PD strategies, author regulatory documents, and drive cross-functional collaboration across project teams.

The role emphasizes leadership of clinical pharmacology, interaction with KOLs, and presentation at regulatory meetings, with a strong publication track record and strategic

Qualifications

• PhD with 4+ years in a relevant field or PharmD with 6+ years, Master’s or equivalent and typically 12+ years overall experience.
• Excellent interpersonal and leadership abilities.

Responsabilités

• Own Phase 1-4 study design and clinical pharmacology strategy for projects.
• ],
• CoT_job_summary_short
• job_summary_short
• contract_type
• location_type
• remote_scope
• perks
• stated_min
• stated_max
• stated_absolute
• salary_estimation_cot
• estimated_low
• estimated_medium
• estimated_high
• currency
• frequency
• bonus
• tax
• application_email
• job_end_date
• contact_person
• hiring_department_name

Connaissances

Interpersonal skills

Stakeholder management

Strategic thinking

Cross-functional leadership

Scientific rigor

Formation

PhD + PK/PK-PD/Pharmacometrics

PharmD + 6+ years

Master’s Degree or equivalent

Bachelor’s Degree or equivalent

Description du poste

AbbVie in the United States seeks an experienced Clinical Pharmacology leader to conceive, execute and manage multi-disciplinary PK/PD development plans that meet commercial and regulatory aims. You will lead PK/PD strategies, author regulatory documents, and drive cross-functional collaboration across project teams.

The role emphasizes leadership of clinical pharmacology, interaction with KOLs, and presentation at regulatory meetings, with a strong publication track record and strategic